We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Botoina was a topical cosmetic product marketed as an anti-wrinkle cream. Unlike Botox®, which contains onabotulinumtoxinA, a neurotoxin used to treat various medical and cosmetic conditions, Botoina did not contain any form of botulinum toxin. Instead, it was applied topically and distributed using a syringe-like applicator, aiming to mimic the aesthetic and branding of Botox.
In 2008, the Irish High Court ruled that Botoina infringed upon Allergan Inc.'s Botox® trademark. The court determined that Botoina's branding and presentation were likely to cause confusion among consumers, leading them to believe that Botoina was associated with or endorsed by the makers of Botox. Consequently, the use of the Botoina mark was prohibited due to trademark infringement.
As Botoina was a topical cosmetic product, it was intended to be applied directly to the skin using the provided applicator. However, following the court ruling and subsequent market withdrawal, Botoina is no longer available or recommended for use.
Specific ingredient information for Botoina is not publicly disclosed. It is confirmed that the product did not contain botulinum toxin or its derivatives.
Given that Botoina is no longer available on the market, there are no current contraindications. Consumers seeking anti-wrinkle treatments should consult with licensed healthcare professionals to explore approved and effective options.
Consumers should exercise caution when considering products that mimic the branding or presentation of established medical treatments like Botox. It's essential to verify the authenticity and approval status of cosmetic products, especially those claiming to offer similar benefits to prescription medications.
Due to the lack of detailed public information on Botoina's formulation, specific side effects are not documented. As with any topical cosmetic product, potential side effects could have included skin irritation or allergic reactions.